Reem Alkilany - University of Kentucky

Education/Academic qualification

Residency, University of New Mexico Hospital

2019

Doctor of Medicine, University of Jordan, College of Medicine

2014

1 Active

Rapcabtagene: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel vs. SOC in Patients Suffering from Systemic Lupus Erythematosus (SLE) with Active, Refractor
Piranavan, P. (PI), Ahmed, S. (CoI), Alkilany, R. (CoI) & Qasrawi, A. (CoI)
Novartis (domestic)
11/8/24 → 12/21/30
Project: Research project